We investigated actions of somatostatin (Som) on voltagegated calcium channels in acutely isolated rat amygdaloid neurons. Somatostatin caused a dose-dependent inhibition of the high voltage-activated (HVA) Ca 2ϩ current, with little or no effect on the low voltage-activated (LVA) current. Nifedipine (2-10 M) reduced the peak current by ϳ15% without reducing inhibition of current by Som significantly, ruling out L-type channels as the target of modulation. The modulation appears to involve N-and P/Q-type calcium channels. After pretreatment with -conotoxin-GVIA (-CgTx) or -agatoxin-IVA, the inhibition was reduced but not abolished, whereas the combined application of both toxins nearly abolished the modulation. The Som analog BIM-23060 mimicked the effects of Som, whereas BIM-23058 had no effect, implicating Som type-2 receptors (SSTR-2). The inhibition was voltage-dependent, being minimal for small depolarizations, and was often accompanied by a slowing of the activation time course. Strong depolarizing prepulses partially relieved the inhibition and restored the time course of activation. Intracellular dialysis with GTP␥S led to spontaneous inhibition and a slowing of the current like that with Som and occluded the effects of the peptide. Dialysis with GDP␤S also diminished the inhibition. A short preincubation with 50 M of the alkylating agent N-ethylmaleimide (NEM) prevented the action of somatostatin. These results suggest a role for NEM-sensitive G-proteins in the Som inhibition. Application of 8-CPT-cAMP and IBMX did not mimic or prevent the effects of Som.
Somatostatin (Som), a tetradecapeptide initially described to inhibit release of growth hormone from the pituitary (Brazeau et al., 1973) , is also widely expressed in the nervous system and has been shown to have modulatory actions in the brain (for review, see Epelbaum, 1986; Inoue and Yoshii, 1992) . Actions of Som include the modulation of potassium (Scharfman and Schwartzkroin, 1988; Schweitzer et al., 1993) and calcium channels in peripheral (Ikeda and Schofield, 1989; Beech et al., 1992; Golard and Siegelbaum, 1993; Shapiro and Hille, 1993; Meriney et al., 1994) and central neurons (Sah, 1990; Wang et al., 1990; Ishibashi and Akaike, 1995) . The multiple actions of Som appear to be mediated by a family of G-protein-coupled receptors (for review, see Bell and Reisine, 1993; Hoyer et al., 1995) . Of the five classes of Som receptors cloned to date, four are expressed in the CNS and two, SSTR-2 and SSTR-3, are highly expressed within the amygdala (Kong et al., 1994) .
The amygdala is formed by a group of nuclei located in the basal forebrain and directly connected with other components of the limbic system: hippocampus and entorhinal cortex. Its functions remain poorly understood, but different experimental approaches suggest crucial roles in emotions (e.g., fear, anxiety) (Adolphs et al., 1994) , social behavior, learning, and memory (for review, see Aggleton, 1993; Davis et al., 1994) . Dysfunctions of the amygdala have also been linked to neurodegenerative disorders, kindling, and temporal lobe epilepsy. Two main, anatomical classes of neurons have been described in the amygdala. Projection neurons are large, pyramidal or stellate-shaped cells that send their axons to targets outside the amygdala; their axons also branch into numerous collaterals to influence neighboring cells within the amygdala. A second main group of cells is formed by smaller local-circuit interneurons containing GABA and choline acetyltransferase. Many local interneurons are also immunoreactive for various neuropeptides, including Som (consult references in Roberts et al., 1982) . Indeed, Som is distributed throughout the amygdala, and some nuclei contain the highest concentration of Som in the brain outside the hypothalamus (Leroux et al., 1993) . Som may function as an inhibitory neurotransmitter within the amygdala because its injection can prevent the spread of temporal seizures (Higuchi et al., 1986) .
In comparison with other CNS structures, and despite its potential clinical relevance for the treatment of different anxiety disorders (e.g., post-traumatic stress syndrome, panic attacks), little is known about the ionic currents present in amygdala neurons and their possible modulation. Only recently have data emerged on the intrinsic membrane properties of the different classes of neurons within the amygdala (Washburn and Moises, 1992; Sugita et al., 1993) . In a brief note, Foehring and Scroogs (1994) described the presence of several pharmacological subtypes of Ca 2ϩ channels in rat amygdala neurons. Here we characterize the effects of Som on voltage-activated Ca 2ϩ channels in acutely dissociated neurons of the rat amygdala. We discriminate the actions on different classes of Ca 2ϩ channels. We also analyzed the possible role of G-proteins in the modula- Figure 1 . Dissociation of neurons from the rat amygdaloid region. A, Photomicrograph of a Nissl-stained section of the rat forebrain, corresponding approximately to plate 27 of the atlas of Paxinos and Watson (1986) . The area punched out for isolation of neurons is marked with an asterisk and is centered on the amygdala complex. The 80-m-thick section was obtained after fixing and resectioning a freshly cut 500-m-thick slice. Calibration bar, 1 mm. B, Digitized phase-contrast photomicrograph of a typical pyramidal-shaped neuron obtained after mechanical dissociation of the amygdala tissue. C, An example of a stellate shape neuron from the amygdala region. Scale bars, 30 m. tory actions of Som and the involvement of specific receptor subtypes.
MATERIALS AND METHODS
Acutely dissociated neurons were obtained from the amygdala complex of 1-to 3-week-old Sprague Dawley rats. Under methoxyflurane anesthesia, rats were rapidly decapitated; the brain was quickly removed, and coronal slices (400 -500 m thick) of the forebrain were cut with a Vibroslicer in a bicarbonate-buffered saline (BBS; 4ЊC) that contained (in mM): NaCl 130, KCl 3, CaCl 2 1.5, MgCl 2 2, NaH 2 PO 4 1.25, NaHCO 3 26, glucose 10. Three to four slices were allowed to recover for 1 hr at room temperature in the same BBS saline bubbled with carbogen (95% CO 2 /5% O 2 ). The amygdala was dissected from the temporal lobe under a binocular microscope (20ϫ) with a home-built micropuncher, consisting of a sharpened 18-gauge stainless steel tube (outer diameter 1.2 mm). One or two tissue pieces containing the amygdala were incubated in an oxygenated Cell-Stir chamber (Wheaton, Millville, NJ) with low-Ca 2ϩ HEPES buffer (LCB) containing pronase E (1-2 mg/ml). Histological verification of the punched area confirmed that the tissue was limited to the amygdaloid complex (see Fig. 1 A) , and in no case was the surrounding pyriform cortex involved. The tissue was digested for 20 -30 min, rinsed several times in the LCB solution, and triturated by aspiration in a graded series of fire-polished Pasteur pipettes. After calcium (0.5 mM) was restored, 200 l of the cell suspension was pipetted into four or five recording chambers that were made from 35 mm plastic Petri dishes and a SYL-GARD insert to reduce the chamber volume (ϳ200 l). One chamber was mounted on the stage of an inverted microscope for recording while the rest were kept under a small hood washed with humidified 100% O 2 . Dissociated cells were kept for a maximum of 3 hr and, afterward, a new cycle of enzymatic digestion was started.
Current recordings (20 -25ЊC) were obtained in the standard whole-cell configuration (Hamill et al., 1981 ) using a List EPC-7 clamp amplifier.
Capacity currents were canceled, and series-resistance compensation (40 -60%) was normally used. A PC/486 clone computer running BASIC-FASTLAB (Indec Systems, Capitola, CA) was used to generate voltage pulses and to acquire and analyze data. Depolarizations were applied every 5-10 sec, depending on the protocol. Patch pipettes (2-4 M⍀) were pulled from 1.5 mm hematocrit glass (VWR), SYLGARD-coated and fire-polished before use. Recording patch pipettes were filled with (in mM): di-Tris-PO 4 70, Tris-base 41, MgCl 2 4, EGTA 10, Tris-ATP 4, Tris-GTP 0.3, phosphocreatine 20, and creatine phosphokinase 50 U/ml (pH-adjusted to 7.2 with Tris-OH). Gigaseals between the patch pipette and the cell membrane were obtained in a modified external solution containing (in mM): NaCl 130, KCl 3, MgCl 2 2, CaCl 2 5, glucose 10, HEPES 10 (pH-adjusted to 7.3 with NaOH). To isolate currents in calcium channels, the extracellular solution was exchanged after seal formation to one containing (in mM): TEA-Cl 150, BaCl 2 5, TTX 0.0005, EGTA 0.1, glucose 10, HEPES 10, and albumin 0.2 mg/ml (pH-adjusted to 7.3 with TEA-OH). After patch rupture, the size of barium currents gradually increased for a variable period of time. Experimental tests were not initiated until the size of the current stabilized (usually ϳ5 min). The solutions to the chamber were exchanged (1-2 ml/min) through a gravityfed system consisting of eight reservoirs controlled by solenoid valves. Potentials in the text and figures have not been corrected for a measured junction potential of Ϫ5 mV.
The amplitude of the whole-cell Ba 2ϩ current was defined as that sensitive to block by 200 -400 M Cd 2ϩ and, unless indicated, all figures display Cd 2ϩ -subtracted traces. In a few cases, the leak current was estimated from scaled hyperpolarizing voltage steps (10 -20 mV) and subtracted. To avoid complications introduced by the change in current time course induced by the peptides, "peak" current measurements after application of agonists were made in a time window (8 -12 msec after the beginning of a step) isochronal to measurements of the control current.
All reagents were of laboratory grade and obtained as follows. Soma- Figure 2 . Cd 2ϩ -sensitive barium currents in amygdala. A, Inward currents obtained in 5 mM external Ba 2ϩ (thick traces) by stepping for 100 msec to Ϫ40, Ϫ10, and 10 mV (top to bottom) from a holding potential of Ϫ90 mV. The smaller amplitude traces were obtained after application of 400 M Cd 2ϩ to the bath. B, Current-voltage relationship for the peak barium current in the same neuron. tostatin was purchased from Peninsula Laboratories (Belmont, CA). The somatostatin analogs BIM-23058 and BIM-23060 were a gift of Dr. R. Murphy (Tulane University). ATP and GTP were purchased from Pharmacia (Piscataway, NJ); pronase E and N-ethylmaleimide (NEM) were from Sigma (St. Louis, MO); guanosine 5Ј-(␥-thio)triphosphate (GTP␥S) and guanosine 5Ј-O-(2-thiodiphosphate) (GDP␤S) were from Boehringer Mannheim (Indianapolis, IN); -CgTx was from Peninsula Laboratories and Bachem (King of Prussia, PA); and -Aga-IVA was from Peptide Institute Kyoto and Bachem.
All values are given as mean Ϯ SEM and, where appropriate, Student's t test was used to determine statistical significance ( p Ͻ 0.05).
RESULTS
The effects of Som were investigated in Ͼ100 neurons from the amygdala of young rats. As shown in the stained histological section of Figure 1 A, the source of neurons was a small (ϳ1 mm diameter) chunk of tissue punched out from the temporal pole of freshly cut coronal brain slices. It included several nuclei of the amygdaloid complex but not surrounding cortical regions such as piriform cortex. From various cell shapes obtained after trituration, we selected only large-or medium-size neurons with a pyramidal or stellate morphology. No obvious differences in properties of these two cell types were observed, and the results were pooled. The distribution of whole-cell capacitances was Gaussian with a mean cell capacitance of 16.5 Ϯ 0.5 pF (n ϭ 75). Figure 1 , B and C, shows phase-contrast photomicrographs of two typical neurons obtained after mechanical trituration of the tissue.
Under conditions optimized to isolate whole-cell Ba 2ϩ currents, steps to Ϫ10 mV from a holding potential of Ϫ90 mV revealed a net inward current that was completely blocked by application of 400 M Cd 2ϩ (Fig. 2) . Typically, during the first minute of recording the peak inward current grew with a roughly exponential time course ( ϭ 107 Ϯ 14 sec; n ϭ 14). Application of 200 nM Som produced a reversible inhibition of the peak Ca 2ϩ -channel current (Figs. 3B, 5). Som was effective in the great majority of neurons, but the maximal inhibition of I Ba showed considerable variability. In 70 of 72 amygdala neurons, the inhibition of peak I Ba was Ͼ5%, with a mean of 19.6% Ϯ 1.2. The extent of inhibition was not correlated with the age of the rat (r ϭ Ϫ0.18; p Ͼ 0.10). The response to long applications (180 sec) of Som showed only a modest desensitization (19.5 Ϯ 1.3%; n ϭ 4), and a second application of the same concentration gave a similar inhibition (data not shown). During brief applications (Ͻ1 min), the inhibi- tion could be elicited repeatedly and showed modest tachyphylaxis. In most cells, inhibition of peak I Ba was accompanied by a significant slowing of the current activation kinetics (Figs. 3B, 4, 5) , characterized by a slow rising phase and no subsequent decay during a 50 msec depolarizing voltage step (Bean, 1989) .
In Figure 3A , three brief applications of increasing concentrations of Som to the same neuron established that the inhibition was dose-dependent. As can be observed in the current traces in Figure 3B , the largest inhibition is also accompanied by the greatest slowing of activation, producing the smallest earlycurrent to late-current ratio (open triangles in Fig. 3A ; note inverted scale). Figure 3C shows the average dose-response of I Ba inhibition to Som. The data points were fitted to the MichaelisMenten equation, with a Som concentration of ϳ8 nM producing half-maximal inhibition. Except where noted, all subsequent experiments were done with 200 nM Som.
The modulation involves Som type-2 receptors (SSTR-2)
To discriminate which receptor subtype(s) is involved in I Ba modulation, we tested the effect of peptide analogs that are relatively specific for the two Som receptors most highly expressed in the amygdala. Figure 4 shows that application of the SSTR-2 agonist BIM-23060 (20 nM) produced a marked, reversible inhibition of the peak I Ba , with a clear slowing of activation kinetics (left inset). In five neurons tested, the inhibition by 20 nM BIM-23060 was 19.2 Ϯ 6.2%. Subsequent application of BIM-23058 (20 nM), which is ϳ1000-fold more selective for SSTR-3 (Raynor et al., 1993a) , caused a modest inhibition of the peak current (3.5 Ϯ 1.1%; n ϭ 5). Finally, application of Som reversibly inhibited the peak current (right inset) to the same degree as 20 nM BIM-23060, although the recovery of the response to BIM-23060 was always slower than for Som.
Modulation by Som varies with voltage
Som did not reduce I Ba equally at all voltages. Shown in Figure 5A are Ba 2ϩ currents in response to three different voltage steps in control (thick lines) and during application of Som (thin lines). The corresponding current-voltage relationship is illustrated in Figure 5B using current measured at 10 msec. At negative potentials (e.g., Ϫ40 mV), the current was small and the effect of Som minimal, consistent with a small effect on the low voltageactivated (LVA) Ca 2ϩ channels (see below). The inhibition seemed largest in the voltage range from Ϫ20 to 0 mV and smaller again at positive potentials. Figure 5C summarizes the voltage dependence of the Som inhibition for 8 neurons.
High voltage-activated (HVA) calcium channels are the primary target of inhibition
In many central neurons, the modulatory effects of agonists are restricted to the HVA component of Ca 2ϩ current, sparing the LVA fraction (Anwyl, 1991; Allen and Brown, 1993) . To examine whether Som selectively inhibited the HVA component of I Ba , we used a three-pulse protocol to isolate the two current components. In many cells, steps to Ϫ30 mV evoke a mostly transient I Ba from a holding potential of Ϫ90 mV and a smaller, nearly noninactivating I Ba from a holding potential of Ϫ60 mV (Fig. 6 A, left) . We defined the LVA current as the difference between these two current traces (Fig. 6 A, left) . Finally, an isolated HVA I Ba was obtained by a voltage step from a holding potential of Ϫ60 to 0 mV ( Fig. 6 A, right) . Figure 6 B is the full time course of the same experiment measuring LVA and HVA currents. The insets are traces of LVA and HVA current before and during application of Som. It is clear that the inhibition by Som is primarily on the HVA component of current. Using this protocol, the LVA current was inhibited by 9.2 Ϯ 2% (n ϭ 9), whereas in the same neurons the HVA current was inhibited by 25 Ϯ 2.7%. Foehring and Scroogs (1994) established that the HVA calcium current in rat amygdala neurons comprises primarily L-, N-, and P/Q-type currents. To determine which component of HVA current is modulated by Som, we tested the ability of specific channel antagonists to block the modulation. In the presence of 2-10 M nifedipine, Som inhibition of I Ba was still robust (Fig. 7A) , suggesting that L-type calcium channels are not the target of Som modulation. On average, Som inhibited I Ba by 19.2 Ϯ 1.8% (n ϭ 7) after application of nifedipine (Fig. 7B) . After the combined application of nifedipine and 2 M -CgTx-GVIA, the inhibition of I Ba was reduced but not abolished (9.5 Ϯ 2.2%; n ϭ 6). Figure   Figure 4 . Som inhibition involves Som type-2 receptors (SSTR-2). Peak current amplitudes elicited by 50 msec pulses to Ϫ10 mV delivered every 10 sec from a holding potential of Ϫ90 mV. Consecutive applications of the selective SSTR-2 agonist BIM-23060 (20 nM) caused a reversible reduction of the peak current and a slowing of the rate of activation (left inset). After current recovery, application of the SSTR-3 agonist BIM-23058 (20 nM) caused a modest inhibition of the peak current. Subsequent application of som (200 nM) reversibly inhibited the peak current (right inset) to the same degree as 20 nM BIM-23060.
Subtypes of calcium channel modulated by Som
7C shows that the P/Q-channel blocker -Aga-IVA (100 nM) only partially removed the Som-mediated inhibition. In the same neuron, coapplication of -Aga-IVA and the N-channel blocker -CgTx-GVIA (2 M) nearly completely eliminated the Som modulation of I Ba . On average, Som inhibition of I Ba was only 1.0 Ϯ 0.5% (n ϭ 4) after inhibition of P/Q-and N-type channels (Fig. 7B) . Thus, N-and P/Q-type channels seem to be the primary targets of modulation.
Facilitation of I Ba by prepulses
To explore further the voltage dependence of Som effects on I Ba , we used a standard double-pulse protocol with a facilitating prepulse before the second pulse (Fig. 8 B, inset) . In neurons recorded with normal pipette solution (0.3 mM GTP), facilitation induced by the 20 msec prepulse to ϩ70 mV was minimal, so the ratio between peak I Ba in pulse P2 and peak I Ba in pulse P1 was close to 1 (1.07 Ϯ 0.01; n ϭ 12) (open circles in Fig. 8 A) . During Som application I Ba , tested during pulse P1, was reduced and slowed. However, the 20 msec prepulse to ϩ70 mV partially restored the peak I Ba during pulse P2 and sped its time course. Thus, the facilitation ratio increased significantly to 1.26 Ϯ 0.02 (n ϭ 12; p Ͻ 0.0001) (Fig. 9B) .
Involvement of G-proteins
We tested for the involvement of G-proteins in several ways. First, we compared the inhibition of cells dialyzed with a pipette solution containing either 0.3 mM GTP (see above) or 2 mM GDP␤S, an antagonist of G-protein activation (Eckstein et al., 1979; Holz et al., 1986; Wanke et al., 1987) . Cells were recorded alternately with each solution. As summarized in Figure 9A , mean inhibition by Som was reduced from 18.2 Ϯ 3.4% (n ϭ 6) in cells recorded with GTP to 7.9 Ϯ 1.0% (n ϭ 6) in those cells recorded with GDP␤S. This difference was significant ( p Ͻ 0.05). Second, we tested the effect of Som in cells dialyzed with GTP␥S, a poorly hydrolyzable activator of G-proteins. Most cells dialyzed with mixtures of GTP and GTP␥S in molar ratios that varied from 3:1 to 12:1 (keeping GTP constant at 0.3 mM) developed a spontaneous inhibition and slowing of I Ba , with almost no further modulation by Som. On average, inhibition by Som in cells dialyzed with GTP␥S was only 6.7 Ϯ 0.6% (n ϭ 7), significantly smaller than in cells from the same preparations dialyzed with GTP ( p Ͻ 0.0001) (Fig. 9A) . Figure 8 B presents a typical example of a neuron recorded with GTP␥S. It is clear that the control I Ba is slow (pulse P1) and smaller than the facilitated current (pulse P2). This gives rise to a facilitation ratio Ͼ 1. On average, the facilitation ratio was significantly larger ( p Ͻ 0.005) in cells dialyzed with GTP␥S (1.19 Ϯ 0.03; n ϭ 7) than in cells recorded with GTP (1.07 Ϯ 0.01; n ϭ 12; Fig. 9B ). In cells recorded with GTP␥S, application of Som did not increase the facilitation ratio further ( p Ͼ 0.1). The spontaneous inhibition caused by GTP␥S presumably is attributable to a high spontaneous turnover rate of GDP/GTP exchange, even in the absence of activation by bound receptors. However, a few cells showed an irreversible inhibition of I Ba after application of Som (data not shown).
A final test for involvement of G-proteins was the action of NEM. NEM, a sulfhydryl-alkylating agent, has been shown to block G-protein-effector interactions by alkylating the ␣-subunits of pertussis toxin (PTX)-sensitive GTP-binding G-proteins (Winslow et al., 1987; Nakajima et al., 1990; Shapiro et al., 1994) . In the neuron presented in Figure 10 A, application of Som caused a 23% inhibition of peak I Ba and slowing of activation (left inset). After bath application of 50 M NEM for 3 min, the inhibition of I Ba by Som was abolished. In paired protocols, Som inhibition was reduced from 22 Ϯ 3 to 1.7 Ϯ 0.9% (n ϭ 8; Fig. 10 B) . This difference was highly significant ( p Ͻ 0.001). In most neurons, NEM also enhanced the rate of current rundown.
The modulation of I Ba by Som is independent of cAMP
Several Som receptors are known to be coupled to inhibition of adenylyl cyclase, as is found, for example, in cultured neocortical neurons (Wang et al., 1989) . To test whether the effects of Som on I Ba were mediated by a reduction in cAMP levels, we determined the actions of Som in cells preexposed for 5 min to 8-CPT-cAMP, a membrane-permeant and poorly hydrolyzable cAMP analog. This treatment changed neither I Ba nor the inhibitory effects of Som (n ϭ 4). In two additional cells, the exposure to 8-CPTcAMP was combined with intracellular dialysis with the phosphodiesterase inhibitor IBMX. Again, we observed no effect on the inhibitory effects of Som on I Ba .
DISCUSSION
We have tested the effects of Som and Som analogs on voltageactivated Ca 2ϩ currents in rat amygdala neurons. We find that Som selectively inhibits the HVA component of the Ca 2ϩ current, and that the G-protein-coupled Som receptor subtype SSTR-2 mediates the inhibition of I Ba . The inhibition involves -CgTx-GVIA-and -Aga-IVA-sensitive components of the Ca 2ϩ current. The inhibition is voltage-dependent and mediated by NEMsensitive G-proteins.
The inhibitory effects of Som on I Ba were rapid, reversible and concentration-dependent. Compared to the effects of Som on I Ca in rat sympathetic neurons (Ikeda and Schofield, 1989; Shapiro and Hille, 1993) , the inhibition of I Ba in the amygdala showed less desensitization. The inhibition was associated with a slowing of Figure 6 . Som inhibits only the high voltage-activated component of current. A, Three-pulse protocol used for the isolation of the LVA and HVA barium current components. The neuron was held at Ϫ90 mV for 5 sec and stepped to Ϫ30 mV. After 5 sec holding at Ϫ60 mV it was stepped again to Ϫ30 mV. The two voltage steps and currents elicited are superimposed on the left side of A. The LVA current was defined as the difference between currents during steps from Ϫ90 and from Ϫ60 mV. After maintaining a holding of Ϫ60 mV for 5 sec, a step to 0 mV elicited a sustained component of current (right side of A) that represents the HVA current in isolation. B, Effect of Som on the currents elicited by the same three-pulse protocol. During application of Som, the transient LVA component of current did not change (left inset), but the HVA barium current was reversibly reduced (right inset). This reduction was accompanied by a slowing of activation. activation kinetics and was partially relieved by strong depolarizing prepulses. A similar marked voltage dependence of Som inhibition and change in gating has been demonstrated in sympathetic neurons (Ikeda and Schofield, 1989; Golard and Siegelbaum, 1993; Shapiro and Hille, 1993) , spinal cord neurons (Bean, 1989) , and pituitary cells (Luini et al., 1986) . In amygdala there seems to be almost no voltage-dependent inhibition of Ca 2ϩ channels in the absence of receptor agonists, and the facilitation of current in the absence of agonist is small. Bean (1989) has proposed that the voltage dependence of the inhibition by many neurotransmitters on I Ca reflects alterations in gating (shift to a reluctant mode) caused by direct interactions between the calcium channel and the G-protein. In sympathetic neurons and in cells transfected with the ␣ subunits of N-and P/Q-type calcium channels, this inhibitory effect appears to be mediated by the ␤␥ subunits of G-proteins (Herlitze et al., 1996; Ikeda, 1996) .
Specific antagonists of Som receptors are completely lacking, and highly selective agonists are not available for all of the Som receptors. However, with some caution we can assign the inhibitory actions of Som on I Ba to SSTR-2 in these cells. The effects of BIM-23060 are not consistent with activation of SSTR-1, SSTR-5, and SSTR-3 because receptor-binding assays on cloned Som receptors indicate that BIM-23060 is not an effective agonist for these three receptors (Raynor et al., 1993a,b) . BIM-23060 does not discriminate between SSTR-2 and SSTR-4, but BIM-23058, which was ineffective, has a 40-fold higher selectivity for SSTR-4 over SSTR-2 (Raynor et al., 1993a,b) . Like all other Som receptors, SSTR-2 is coupled to intracellular effectors through GTPbinding regulatory proteins. Autoradiographic studies have shown that the amygdala expresses high levels of SSTR-2 mRNA (Kong et al., 1994) . The lack of effect of cAMP on I Ba inhibition is also consistent with the possible involvement of SSTR-2 because this Som receptor lacks functional coupling to adenylyl cyclase (Law et al., 1993) .
Recordings with the nonhydrolyzable GTP analog GTP␥S caused a gradual decrease in the amplitude of I Ba and a gradual The filled circles represent peak current amplitudes (measured at 10 msec) elicited by 50 msec pulses to Ϫ10 mV delivered every 10 sec, from a holding potential of Ϫ90 mV (pulse P1). After 5 sec at Ϫ90 mV, a second, identical pulse was applied (pulse P2) but preceded by a 25 msec prepulse to ϩ70 mV and a 10 msec repolarization to Ϫ90 mV to close calcium channels. The open circles represent the ratio peak current amplitude elicited by pulse P2 and pulse P1 (facilitation ratio). Application of 200 nM Som (som) caused a strong reduction of the peak current and a slowing of the activation time course in the control pulse (pulse P1). Current inhibition and slowing were substantially reduced when depolarization was preceded by a brief prepulse (pulse P2). B, Currents elicited in a neuron recorded with an electrode containing 50 M GTP␥S (and 300 M GTP). Identical protocol as in A. Note the substantial facilitation of the current elicited by the prepulse in control conditions (facilitation ratio Ͼ 1). Som inhibition of peak current was very modest (left and right insets), and Som did not induce a further facilitation of the current by the prepulse. Calibration bars, 20 msec and 1 nA. slowing of activation kinetics. These effects were identical to, and occluded, those produced by Som. This suggests that in amygdala neurons GTP␥S can exchange for GDP on a G-protein in the absence of apparent receptor stimulation. Similar results have been reported for the transmitter inhibition of N-and P/Q-type Ca 2ϩ channels in other central and peripheral neurons (Dolphin and Scott, 1987; Wanke et al., 1987; Mintz and Bean, 1993) . The inhibitory effects of GDP␤S were more modest than those reported in some systems (e.g., Holz et al., 1986 ) but still stronger than in rat sympathetic neurons (Ikeda and Schofield, 1989; Shapiro and Hille, 1993) .
The Som-induced inhibition of I Ba in amygdala neurons was completely prevented by brief preincubations with NEM. Using a similar protocol in rat sympathetic neurons, which have several well characterized G-protein-coupled signaling pathways (Hille, 1994) , Shapiro et al. (1994) found that the actions of NEM were specific for modulatory pathways involving PTX-sensitive G-proteins. In cultured cortical neurons (Wang et al., 1990 ) and in sympathetic neurons, the inhibition of I Ca by Som is wholly PTX-sensitive (Ikeda and Schofield, 1989; Shapiro and Hille, 1993) . Similarly, Som inhibition of I Ba in the amygdala is likely to involve PTX-sensitive G-protein(s). In contrast, Som-induced activation of a K ϩ conductance in rat septal neurons was not sensitive to PTX (Twery et al., 1991) . Two PTX-sensitive G-proteins, G i␣3 and G o␣ , selectively associate with the Som receptor subtype SSTR-2 (Law et al., 1993) , and studies by Kleuss et al. (1991) indicate that G o␣2 mediates the inhibitory effects of Som on I Ca in pituitary GH 3 cells. It remains to be established which specific G-protein(s) mediates the effects of Som on calcium channels in the amygdala. Our results were obtained under strong chelation of intracellular calcium (10 mM EGTA). Therefore, we cannot exclude modulatory actions that are disrupted by a high concentration of Ca 2ϩ chelators (Bernheim et al., 1991) . Nevertheless, unlike results obtained with other neurotransmitters, modulation of calcium channels by Som in rat sympathetic neurons involves only a fast, membrane-delimited pathway that is not affected by calcium chelators (Shapiro and Hille, 1993) .
We have found that both N-and P/Q-type components of I Ba are inhibited by Som. Inhibition of these two Ca 2ϩ currents by a single transmitter has been demonstrated in other neurons such as spinal interneurons, inhibited by activation of GABA B receptors (Mintz and Bean, 1993) , brainstem motoneurons, inhibited by serotonin (Bayliss et al., 1995) , and neostriatal neurons, inhibited by dopamine (Surmeier et al., 1995) . Other transmitters, in particular adenosine, can have differential effects on N-and P/Q-type calcium channels. For example, in CA3 pyramidal cells, activation of A 1 receptors by adenosine inhibits N-type channels, whereas activation of A 2b receptors potentiates P/Q-type channels (Mogul et al., 1993) . In contrast to the effects of Som in the amygdala, in rat CA1 pyramidal neurons Som inhibited only the N-type calcium current (Ishibashi and Akaike, 1995) .
Functional implications
In rats the Som gene is well expressed before birth (Burgunder, 1994) , suggesting a functional role in the immature brain. Many nonpyramidal neurons of the amygdala are immunoreactive for Som (McDonald and Pearson, 1989) . In addition, the amygdala is richly innervated by numerous afferent nerve terminals immunoreactive for Som (Roberts et al., 1982) . Electron microscopic studies indicate that some of these terminals synapse on somata and dendrites of amygdala neurons (Aylward and Totterdell, 1993) . Som inhibition of I Ca may influence the excitability of amygdala neurons postsynaptically, by modulating the amplitude of the Ca 2ϩ -dependent afterdepolarization and afterhyperpolarization conductances that follow the action potential of amygdala pyramidal neurons (Rainnie et al., 1993; Sugita et al., 1993) . In addition, liberation of Som near axonal terminals of amygdala pyramidal neurons could modulate N-and P/Q-type calcium channels, reducing presynaptic entry of Ca 2ϩ and thus inhibiting transmitter release.
